NAKA MASAO
No ORCID on file
· 85 papers in corpus
· active 2001-2005
Frequent coauthors
- KONISHI MIKIO 51
- KONNO MITOSHI 51
- KISHIMOTO TADAMITSU 51
- SAKAKI KATSUHITO 51
- TAKAHASHI Kanji 34
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2005
An IL-6 production inhibitor which comprises a hydroxamic acid derivative of formula (I) (wherein all the symbols have the same meanings as defined in the specification), an equivalent thereof, a non-toxic salt thereof or a prodrug thereof …
2004
Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …
2004
Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …
2004
Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …
2004
Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …
2004
Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …
2004
Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …
2004
Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …
2004
Hydroxamic acid derivatives of the formula (I)(wherein all the symbols have the same meaning as defined in the specification.),non-toxic salt thereof or prodrugs thereof.The compounds of the formula (I) inhibit producing IL-6, so it may be …